Site Members can sign up for company wide alerts
Lawsuit Overview
January 7, 2022 - An investor in shares of Talis Biomedical Corporation (NASDAQ: TLIS) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Talis Biomedical Corporation in connection with certain allegedly false and misleading statements made in connection with the Company’s February 2021 initial publi...
You must register (for free) or login to view the entire case.